Adamax represents an engineered derivative of the heptapeptide Semax (Met-Glu-His-Phe-Pro-Gly-Pro), incorporating N-terminal acetylation and C-terminal adamantane-glycine modification for improved enzymatic stability and blood-brain barrier penetration characteristics. This structural optimization supports extended research into neurotrophic factor modulation, hepatocyte growth factor/c-Met potentiation, and downstream cascades relevant to neuroplasticity and cognitive pathway modeling.
Synthesized under GMP-aligned conditions, Adamax is provided as lyophilized powder with rigorous quality assurance, including sequence verification by mass spectrometry, purity analysis via HPLC, and a full third-party Certificate of Analysis (CoA) for every batch to facilitate reliable experimental reproducibility.
Key Scientific Features
- ≥99% purity confirmed by reverse-phase HPLC and electrospray mass spectrometry.
- Verified sequence: Ac-Met-Glu-His-Phe-Pro-Gly-Pro-Ala-Gly-NH₂ (adamantane-modified Semax analog).
- Lyophilized format designed for maximum stability and aseptic reconstitution in neuronal culture or in vivo models.
- Batch-specific third-party CoA documenting purity, identity, content, and contaminant screening.
- Produced in GMP-aligned, ISO-compliant facilities.
- Optimized for studies on enhanced neurotrophic signaling, synaptic protein expression, and neuroregenerative mechanisms compared to parent Semax.
Research-Referenced Attributes (Pre-clinical literature observations; no therapeutic claims)
- Pre-clinical models of Semax and analogs indicate upregulation of BDNF protein and mRNA levels in rat hippocampal and basal forebrain regions, accompanied by increased TrkB tyrosine phosphorylation and exon-specific BDNF transcription (PMID: 16996037, https://pubmed.ncbi.nlm.nih.gov/16996037/; PMID: 16635254, https://pubmed.ncbi.nlm.nih.gov/16635254/).
- Structural modifications in related analogs associate with potentiated HGF/c-Met signaling, leading to enhanced synaptogenesis, dendritic spine formation, and dendritic arborization in neuronal cultures (PMID: 25187433, https://pubmed.ncbi.nlm.nih.gov/25187433/).
- In transgenic APP/PS1 mouse models, related angiotensin IV-derived peptides (including HGF/c-Met modulators) link to restored cognitive performance via PI3K/AKT pathway activation and reduced amyloid-related impairments (PMID: 34827486, https://pubmed.ncbi.nlm.nih.gov/34827486/).
- Adamantane modifications in peptide analogs contribute to improved stability, prolonged in vivo duration, and efficient CNS delivery, supporting extended investigations into neuroplasticity under stress or aging conditions (various analog studies; e.g., Semax BDNF/TrkB modulation in PMID: 16996699).
Why Researchers Choose Nationwide Peptides Adamax
- Aligns with advanced Semax analog designs featuring adamantane for superior stability and CNS access in neurotrophic models.
- Ensures full analytical transparency: HPLC ≥99%, MS sequence confirmation, and downloadable batch CoA.
- Delivers batch-to-batch consistency essential for longitudinal neuroplasticity and synaptic studies.
- Preferred by laboratories exploring BDNF/TrkB pathways, HGF/c-Met potentiation, and neuronal resilience mechanisms.
- Catalog includes standard vial sizes with competitive research pricing and bulk options.
Disclaimer
For Research Use Only. This product is supplied strictly for in vitro and in vivo laboratory investigations by qualified researchers in controlled experimental settings. Statements regarding this product have not been evaluated by the FDA. It is not intended for human consumption, injection, diagnostic use, therapeutic application, or any non-research purpose.
